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ABSTRACT
Purpose: Preclinical studies and clinical observations suggest that amplitude modulation (AM) below
100 kHz may enhance the intratumoral power absorption of radiofrequency hyperthermia at
13.56MHz; however, it remains unclear whether AM induces temperature-dependent effects.
Methods: We established tumor models assuming typical tumor architectures or cell suspensions to
analyze the effects of additional power dissipation. The preconditions for demodulation at cell mem-
branes in situ were outlined. The bioheat transfer equation was solved analytically for the selected
models and the possibility of circumscribed temperature increases (point heating) with dependency
on the specific absorption rate (SAR) peaks was estimated for centimeter down to nanometer scales.
Results: Very-low-frequency (VLF) AM radiofrequency can increase the SAR in the extracellular space
or necrosis of tumors as compared to radiofrequencies alone. Such modulation-derived SAR peaks can
induce higher temperatures (hot spots) in tumors with necrotic areas of millimeter to centimeter size.
However, for lesions <1 cm, excessive (unrealistic) SAR > 1000, 10,000 and 1014W/kg for diameters of
5mm, 1mm and 10nm (nanoheating), respectively, would be required to explain the cell kill
observed in pre-clinical and clinical data, even with VLF modulation.
Conclusion: Our analysis suggests that VLF AM of radiofrequency hyperthermia for a theoretical tumor
model cannot induce relevant temperature-dependent effects, as the associated temperature increases
caused by the resultant SAR peaks are too small. Further investigation of possible non-temperature-
dependent effects is recommended.
ARTICLE HISTORY
Received 10 July 2019
Revised 3 November 2019
Accepted 7 November 2019
KEYWORDS
Radiofrequency hyperther-







Radiofrequency (RF) hyperthermia using annular phased
array (APA) techniques (70–140MHz), capacitive systems
(8–13.5MHz) or local applicators (200–1000MHz) has been
validated for various tumor entities [1–5]. The basic physics,
thermal dose concepts and associated planning are well
understood [6–8]. Typically, only a specific absorption rate
(SAR) of 10–20W/kg is achieved in difficult-to-heat tumors;
this can approach 60–100W/kg under favorable conditions
(i.e., for easy-to-heat tumors) [6]. The steady-state tempera-
ture increase h [C] in extended tumors is also influenced by
the tumor perfusion w [ml/100 g/min] and can be estimated
using a simple equation involving the SAR: h¼ 1.5 SAR/w.
Therefore, the final intratumoral temperature is widely prede-
termined by anatomical and physiological determinants. In
clinical practice, the most significant parameter as regards
increased RF heating effectiveness is increasing the total
power to the upper limit tolerated by the patient. Therefore,
based on successful clinical trials (e.g., for cervical cancer),
we can assume a typical total power >600W for APA
systems [6,9] and an even higher total power >800W for
capacitive techniques [10,11].
Recent clinical data [12] suggest that RF heating at
13.56MHz in conjunction with amplitude modulation (AM) at
very low frequencies VLF of the order of hertz to 10kHz (called
‘modulated electro hyperthermia [mEHT]’) is effective, and per-
mits use of much lower power levels [6,9–11]. A randomized
trial [12] targeting locally advanced cervical cancer (standard
radiochemotherapy with or without mEHT) revealed superior-
ity of the experimental arm with respect to response/local
control, with a total power of only 130W. Further, the temper-
atures in the tumor were conceivably below those reported in
[6,9–11]. Therefore, we hypothesize that additional non-tem-
perature-dependent effects affected the results.
Moreover, in another recent study, mEHT with 40–150W
was applied as mono-therapy (without radiotherapy or
chemotherapy) to target recurrent glioblastoma/astrocytoma
III after standard treatment [13]. The researchers found
objective remissions with volume reduction (i.e., complete/
partial remissions) in one third of 50 patients, which is a sur-
prisingly high response rate.
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An additional effect of VLF-modulation is also evidenced
by preclinical studies on cell suspensions and experimental
tumors. In those works, the researchers compared water bath
hyperthermia [14–17] and RF hyperthermia [18] with a modu-
lated capacitive heating technique (i.e., mEHT) using a carrier
frequency  of 13.56MHz. Various experiments indicated
stronger effects when mEHT was applied compared with
water bath/infrared heating with the same temperature
adjustments (typically 38 C or 42 C). Notably, Yang et al.
[18] estimated a temperature difference of approximately
4 C with comparable apoptotic cell rates for water bath
heating and mEHT heating, which were performed at 46 and
42 C, respectively.
Therefore, additional cell kill mechanisms may exist
beyond the homogeneous temperature elevation (via water
bath heating or infrared heating) achieved via VLF-modula-
tion. Researchers often explain such data by assuming the
occurrence of undetected temperature peaks (hot spots) dur-
ing mEHT application. In such cases, the higher temperatures
could primarily be due to the associated heterogeneous tem-
perature distributions, which are inadequately sampled by
conventional thermometry techniques.
This study explores the effects of mEHT application with
regard to potential SAR peaks, which may cause hot spots. A
theoretical approach is adopted, with the fundamental bio-




We adopted various tumor models based on typical tumor
architectures or cell suspensions to analyze the effect of add-
itional power dissipation. Figure 1 shows a single necrotic
sphere of diameter d containing extracellular fluid (ECF) illumi-
nated by constant SAR in an infinite medium with perfusion w
and 0 SAR. Based on this model, we studied the temperature
effects of high SAR peaks of extension d. The major advantage
of this model is the existence of an analytical solution for the
temperature distribution, which enables assessment down to
microscopic dimensions (e.g., 10–100 mm).
Figure 2 shows a simplified three-dimensional model
applicable to cell suspensions and some tumors (with typical
microenvironments), consisting of cubical cell clusters of
extension di (where index ‘i’ indicates ‘intracellular’). These
suspensions or tumor cell clusters are located in an extracel-
lular medium with distance de (index ‘e’ indicates
‘extracellular’) between the cell clusters in all spatial direc-
tions x, y, z. The parameters di/e may be selected to represent
a variety of tumor architectures, from predominantly
hydrated/necrotic (de  di) to solid (de  di) tumors. Clearly,
the parameters di/e can vary with position and indicate a
local property of the tumor. The intra-/extracellular spaces
Vintra/Vextra can be estimated from the relations
Vintra ¼ N di3 ¼ L3  ½di=ðdi þ deÞ3 and Vextra
¼ L3  f1 ½di=ðdi þ deÞ3g, (1)
where N¼ [L/(diþ de)]3 indicates the number of cells or cell
clusters in the tumor and L is the tumor size (Figure 2). The
typical tumor microenvironment is characterized by high pro-
portions of ECF and/or necrosis, which correlates with the
common increased T2-intensity in magnetic resonance imag-
ing of tumors. In the literature, we find typical data of >80%
water content, i.e., <20% intracellular macromolecule con-
tent [19]. This yields >60% ECF, as illustrated by Figure 2.
Note that a relationship of di¼ 2 de yields 70% extracellular
space according to Equation (1); this space is typically com-
posed of 65% ECF and 5% plasma (in the vascular sys-
tem) [20].
Conversely, in normal tissue, the total water content is
60% (intra-, extracellular, plasma) and, consequently, the
macromolecule content is 40% [20]. This yields an extracellu-
lar space of 20%, as illustrated true-to-scale in Figure 3. That
figure shows the typical structure of normal tissue (e.g.,
muscle or organ) containing functional units of parenchymal
Figure 2. Simplified tumor model with cubical tumor cells or cell clusters of
extension di (‘i’ for intracellular) in extracellular medium ‘e’ of width de.
Assuming a tumor cube of edge length L [cm], we can determine the number
N3 of tumor cell clusters from di and de. The tumor is more solid and more
hydrated for di> de and di< de, respectively. The cell membrane has 5-nm
thickness. The cell cluster arrangement is continued in all directions. The figure
illustrates a di¼ 2 de relationship yielding 70% extracellular fluid (ECF, see
text). This is a three-dimensional model with the coordinate origin and x/y axes
plotted for analytical solution (Equations 7–9).
Figure 1. Simplified model of necrosis as sphere of diameter d with constant
specific absorption rate (SAR) inside and perfusion w¼ 0. The sphere is
embedded in an infinite medium with 0 SAR and arbitrary w.
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cells arranged by connective tissue strands. An extracellular
space proportion of 20% is achieved for di 	 14 de, accord-
ing to Equation (1). The cell-membrane interacting area in
normal tissue is further diminished by the cell interconnec-
tions (as represented by the tight junctions in Figure 3).
Electrical constants
Table 1 summarizes the electrical properties of the intracellu-
lar and extracellular spaces used in the model of Figure 2,
which are assumed as constant from direct current (DC) until
100MHz [21,22]. The extracellular space is an electrolytic
fluid similar to a 0.9%-NaCl solution with frequency-
independent high electrical conductivity re¼ 1.2 S/m. The
lower electrical conductivity ri¼ 0.3 S/m of the cytoplasm is
due to water bounded by proteins and may vary according
to cell type [19]. For a cell membrane (index ‘m’) of 5–10 nm
thickness, low dielectric values and extremely low electrical
conductivities rm have been reported for frequencies
<1MHz with increasing rm above 1MHz [22].
For biological tissue, the relative permittivity is known to
be strongly dispersed (a- and b-dispersion in the kilohertz
range and at some 100 kHz, respectively) as extensively
studied in the past [19,23–25]; this is not reflected in Table 1,
for the following reasons. First, these dispersions were found
in normal tissue with much higher macromolecule and mem-
brane concentrations than in tumors. Second, the relative
permittivity is relatively unimportant for our low-frequency
(<100 kHz) considerations, which are dominated by r [19].
The electrical behavior at VLF is determined by the con-
ductivity re (Table 1), because the cell membrane acts as an
isolator. Therefore, the different architectures found in
tumors (Figure 2) compared with normal tissue (Figure 3)
yield higher r at audio frequencies. However, these notable
differences may not be valid for every tumor and depend on
the specific microscopic structure. Above 1MHz, the mem-
branes become increasingly transparent/conducting and the
intracellular SAR SARi [W/kg] approaches 25% of the extracel-
lular SAR SARe (derived from the ri/re ratio given above).
Therefore, in tumors, mean values rTM (where index ‘TM’
indicates ‘tumor’) of 0.6–0.8 S/m between ri and re are rea-
sonable assumptions for RF hyperthermia planning systems
(10–500MHz) [26,27].
The power per mass for alternating current (AC) electrical
fields E is given by the relation SAR [W/kg]¼ (r/2q)E2, with
the assumed simplification that the density q¼ 1 kg/l for all
tissue. The typical mean SAR values achieved in tumors using
clinical hyperthermia systems, either APAs or capacitive tech-
niques, are 10–60W/kg [6]; the corresponding E fields have
amplitudes of 100–300 V/m (Table 1).
For m 
 1MHz, dielectric power dissipation is dominant;
i.e., the rotational or vibrational energies of atoms and ions
generated via interaction with E(m). The SAR is split into dif-
ferent SARi/e.
For m  1MHz, however, conductive power dissipation
becomes dominant. We assume that the cytoplasm region is
surrounded by practically perfectly insulating cell mem-
branes. Therefore, almost no current enters the cytoplasm
and SARi becomes negligible. Thus, the power is deposited
via ion currents in the widely connected extracellular space
that characterizes many tumors.
Demodulation
VLF-related conductive power dissipation may be possible in
tumors through application of VLF-AM for a VLF of some kHz
and an RF  of 13.56MHz [28]. To cause VLF-currents in the
tumor, this particular tumor tissue must act as a demodula-
tor. In terms of an equivalent circuit, the tumor cell mem-
branes operate like barrier-layer rectifiers (diodes) and form a
capacitance C (mF/cm2), while the ECF and specific channels
act as resistors (R 100 X  [cm2]), as illustrated in Figure 4.
That diagram shows the basic circuitry of the earliest receiver
known as the ‘crystal radio receiver’ (see Wikipedia).
Demodulation is realized by rectification (where the cell
membrane is analogous to a diode) in conjunction with
smoothing (via C and R). The time constant RC must be
between the cycle times of the carrier (1/) and the modula-
tion frequency (1/VLF) for a proper (distortion-free) demodu-
lation [29]. We expect considerably a greater demodulation
in the tumor, which is composed of widely connected and
abundant ECF adjoining rectifying membranes. Because the
other (preferably normal) tissue has no strong ability to
demodulate, the AM carrier signal passes through without
generation of VLF-currents. Thus, when both  and VLF are
appropriately selected, VLF-conduction may only occur in a
limited volume of the exposed body region. This is particu-
larly valid for tumors having suitable microenvironments.
Figure 3. Simplified model of normal tissue such as muscle or liver. The extra-
cellular space has a share of 20%, yielding this scale drawing (see text).
Therefore, the functional units are considerably larger than the tumor cell clus-
ter of Figure 2 and de  di. Because of the narrow interstitium of only a few
micrometer, the membrane accessibility as regards electrical processes may be
reduced. The membrane area is further decreased by the interconnections
between the normal tissue cells (e.g., tight junctions), as sketched between the
functional units.
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In the case of a basic double-sideband (DSB) AM scheme
(DSB-AM),  is fully modulated by VLF frequencies with a
modulation index m¼ 1. Then, the total power of the side-
bands is equal to half the carrier power [29]. The power rela-
tionship between the carrier and sidebands can be modified
in favor of the latter, e.g., by using a DSB reduced carrier
(DSB-RC) transmission. Therefore, the sideband power can
range from half the total RF power P(m) for DSB-AM with
m¼ 1 to a multiple of P(m) for DSB-RC, and will increase the
VFL-related power transfer in the tumor ECF. This may yield
enhanced generation and absorption of VLF-currents. In con-
sequence, the local SAR in the tumor ECF generated by VLF-
demodulation and conduction, SARTM(VLF), can be higher
than the (mean) SAR in the tumor generated by the carrier
frequency SARTM() alone. We describe this effect by the fol-
lowing equation:
SARTMðVLFÞ ¼ K  SARTMðmÞ (2)
In our calculations, we take K¼ 1–100 as an assumed
power range in order to estimate the effect due to enhanced
VLF-current conduction in tumors. A special modulating fre-
quency that maximizes K may exist in the VLF-range,
depending on the individual tumor architecture. Matching of
the modulated power through proper selection of the modu-
lating frequency spectrum is a possible strategy for increas-
ing/maximizing K, which is in principle unknown for every
new case [28].
Note that an increase of SARTM(VLF) up to 100W/kg in the
ECF of a 100-ml tumor (6 cm extension) requires a total
power of only 10W, which is a small portion of the total
power from the amplifier. Furthermore, assumption of K> 10
(or even K> 2) in Equation (2) is probably unrealistic.
However, such a hypothesis is tested to clarify whether tem-
perature-dependent effects can occur as a consequence of
exceedingly high SAR in a circumscribed necrosis with diam-
eter d (Figure 1) or in a tumor ECF of width de (Figure 2).
BHTE formulation
On a microscopic level, the SAR distribution is heteroge-
neous and follows the rules outlined in the previous section.
However, determination of the corresponding temperature
increase h is much less straightforward, because of the rapid
heat redistribution that occurs at microscopic dimensions of
size d¼ 1–10 nm according to the thermal equilibration
relaxation time s¼ d2c/j, listed in Table 1 using the con-
stants c, j in Table 1.
The value of h in the steady state is approximated by the
well-known BHTE [30] with source term SAR and an omnidir-
ectional w [ml/100 g/min]:
ðj=qÞr2hþ qbcb  w  hþ SAR ¼ 0, (3)
Table 1. Compilation of physical constants and formulas used in main text [6,21–22]. For our purposes, the frequency range can
be restricted to <100MHz. The relaxation times depending on the spot size are given below (see Discussion).
j¼ 0.6 W/m/C Thermal conductivity (tumor)
q¼ 1.0 kg/l Density (water)
c¼ 4000Ws/kg/C Heat capacitance (tumor)
re¼ 1.2 S/m Extracellular medium conductivity (DC – 100MHz)
ri¼ 0.3 S/m Cytoplasm conductivity (DC – 100MHz)
rm¼ 3 107 S/m Membrane conductivity (<1MHz)
cm¼ em/d¼ 0.9 102 F/m2 Membrane capacitance
ﬃ1 mF/cm2 em¼ 4.4 1011 As/Vm, d¼ 5 nm (membrane)
er/e¼ 72.5 Extracellular medium relative permittivity (DC – 100MHz)
er/i¼ 72.5 Cytoplasm relative permittivity (DC – 100MHz)
er/m¼ 5 Membrane relative permittivity (<10MHz)
E¼ 100–300 V/m E-field for SAR ¼ 10–60 W/kg
E¼ 200 V/m for SAR ¼ 25 W/kg
s¼ d2 q c/j Relaxation time for hot spot of extension d
s¼ 10 s for d¼ 1mm
s¼ 101 s for d¼ 100 mm
s¼ 103 s for d¼ 10 mm
s¼ 109 s for d¼ 10 nm
Figure 4. Equivalent circuit diagram of tumor, acting as demodulator of AM RF
frequency at 13.56MHz. The membranes (top left) are comparable to a rectifier
diode (top right), because they have high permeability/conductivity for Kþ and
Cl ions (forward direction) and are much less permeable for Naþ and A
(backward direction). The resistance R and capacitance C of the membranes or
cell formations of the tumor determine the demodulation condition (see text).
The electrical parameters can be derived utilizing the parameters of Table 1.
The power absorption of the tumor may be increased by adjusting the carrier
frequency v or the modulation frequency spectrum to the specific tumor (bot-
tom left) and its electrical attributes (bottom right).
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using the constants j, q(water), qb(blood), c(water), cb(blood)
described in Table 1.
Results
The power deposition patterns (SAR) in Watts per kilogram
can be estimated on a microscopic level for nanotherapy or
various electromagnetic techniques. In the case of mEHT, we
employ simple three-dimensional models and assume arbi-
trarily high SAR in the ECF, which is deposited by currents at
low frequencies (Figures 1 and 2). Then, the temperature dis-
tribution can be evaluated utilizing numerical methods; how-
ever, this is a difficult task in the case of microscopic
dimensions (down to nanometer scale). Therefore, in this
study, we adopted an alternative approach and searched for
analytical solutions, which are not restricted by physical
dimensions, memory space, computing speed or numerical
inaccuracies. We investigated whether undetected small, or
even microscopic, hot spots (exposed to temperature
increases >5–6 C) can explain the data reported in
Refs. [12–18].
In the following, we report deduction of the analytical sol-
utions of the BHTE (Equation 3) for the models shown in
Figures 1 and 2. The inserted physical constants are listed in
Table 1.
Analytical solution for Figure 1 model
We formulated the BHTE in spherical coordinates:
o2h=or2 þ ð2=rÞ  oh=or – ðqbqcb=jÞ w h
¼ 0 for r 
 1=2d, (4a)
o2h=or2þ ð2=rÞ  oh=orþ ðq=jÞ  SAR¼ 0 for r  1=2d: (4b)
After straightforward calculation with hin(½ d)¼ h0 and
hin(0)¼ hmax, we achieved (assigning the parameters of Table
1 and taking r in centimeter):
houtðr 
 1=2dÞ ¼ h0  ðd=2rÞ  exp





hinðr  1=2dÞ ¼ hmax – 0:028 SAR r2, (5b)
where hout, hin, h0 and hmax are the temperature elevations
outside, inside, at the edge and at the center of the sphere,
respectively. Note that hmax is also the maximum tempera-
ture increase. Hence, the temperature elevation h(r) exhibits
an inverted parabola inside the sphere and an exponential
decline outside.
Finally, employing the following boundary conditions at
the edge ½d of the sphere:
hinð1=2dÞ ¼ houtð1=2dÞ and ohin=orð1=2dÞ ¼ ohout=orð1=2dÞ,
we obtained formulas allowing estimation of the tempera-
ture elevations h0 and hmax [C] for the sphere depending on
d [cm], SAR [W/kg] and w [ml/100 g/min]:





hmax ¼ h0 þ 0:007 SAR d2, (6b)
and for
w ¼ 0 : hmax ¼ 0:021 SAR d2: (6c)
Note that the induced temperature elevation increases
(only) linearly with SAR, but has a fast quadratic decay with
declining d.
Analytical solution for Figure 2 model
We formulated the BHTE in Cartesian coordinates of x, y
and z:
r2hþ ðq=jÞ  SAR ¼ 0: (7)
The general solution is
hðx, y, zÞ ¼ Aðx2 þ y2 þ z2Þ þ Bðx þ y þ zÞ þ C: (8)
By substituting (8) into (7), we obtained A¼ –(q/6 j) 
SAR and, for reasons of symmetry, B¼ 0 (h(–x, 0, 0)¼ h(þx, 0,
0)). Defining the coordinate origin in the center of the extra-
cellular space ‘e’ according to Figure 2, we assumed for every
direction x, y, z the same h(x, y, z) behavior. In the center of
the aqueous space the temperature increase is maximal,
he(0,0,0)¼ hmax. By considering ½de in every direction x, y, z
to the furthermost point at the cell membrane, we found the
minimum temperature increase hmin, i.e., hmin¼ he(½de, ½de,
½de). Then, assuming SARi¼ 0, we obtained for the tempera-
ture difference Dh [C] (Figure 2):
Dh ¼ hmaxhmin ¼ ðq=8jÞ  SARe  de2 ¼ 0:021 SARe  de2,
(9)
where SAR is in Watts per kilogram; de is in centimeter,
j¼ 0.006W/cm/C and q¼ 0.001 kg/cm3 (Table 1). Note that
the predicted (additional) temperature increases hmax or Dh,
respectively, are equal for both models (Figure 2/Equation 9
versus Figure 1/Equation 6c).
We assumed a mean SAR() at the tumor within the range
of 10 to 60W/kg (from difficult to easy to heat, respectively).
Equation (2) predefines the additional power provided by
the VLF-AM to the tumor stroma, either a necrosis with
diameter d or tumor ECF of width de.
Equations (5) and (6) were used to evaluate the likelihood
of ‘point heating’, i.e., the creation of circumscribed tempera-
ture elevations (hot spots) by high SAR peaks of limited size.
Advantageously, for arbitrary values of SAR and d (i.e., for a
heated sphere of diameter d), h could be calculated and the
actual temperature estimated by adding a systemic tempera-
ture of 37.5 C. We quickly recognized that effective heating
in small volumes of microscopic dimensions<millimeter
scale is virtually impossible, if realistic SAR are assumed.
Figure 5 (top) illustrates that, in a sphere of 1-cm diam-
eter, SAR¼ 200W/kg is required for temperatures >41.5 C.
Further, if SAR¼ 100W/kg is achieved (still challenging), the
temperature elevation is only 39.6 C. If we assume the
occurrence of SAR peaks in volumes of 5mm (Figure 5, bot-
tom), excessive SAR¼ 800W/kg is required in order to
achieve a temperature >41.5 C. Even SAR¼ 400W/kg yields
unsatisfactory temperatures of 39.6 C. In summary, either
unrealistically high SAR (> hundreds of Watts per kilogram)
and/or large heated volumes (> centimeter scale) are neces-
sary to achieve effective temperatures. In addition, according
to the curves of Figure 5, the temperature increase scales
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larger than the diameter of the absorbing area to the sur-
roundings. Consequently, a temperature elevation on a
macroscopic level is expected. Therefore, hot spots at micro-
scopic dimensions of<millimeter scale with no macroscopic
temperature elevation are very unlikely according to our
physical analysis.
Applying Equations (6c) and (9), we calculated hmax for
the two tumor models. Interestingly, the same formula was
used and the (local) SAR values (for either heating of the
sphere with diameter d or the ECF of width de) were
inserted. To be more specific, we defined the ‘critical lesion
diameters’ dc as the minimum d or de required to achieve an
effective temperature of 43.5 C or higher in the center, i.e.,
hmax 
 6 C, for a given SAR (assuming a systemic tempera-
ture of 37.5 C). The relationship between dc and SAR is given
by the following simple formulas:
dc½cm ¼ ð6=0:021=SAR½W=kgÞ1=2 ¼ 16:90=SAR1=2 (10a)
or
SAR ¼ 285:6=dc2: (10b)
Figure 6 illustrates the dependency between dc (referring to
the models of Figures 1 and 2) and SAR. For difficult-to-heat
tumors, we expect only 10W/kg in the lesion. Hence, we
need large necrotic areas (dc>5 cm) in order to obtain effect-
ive temperatures (>43 C) using such low RF levels. For easy-
to-heat tumors with very high SAR, the obtained dc
approaches one centimeter. However, extremely local SAR
peaks >1000W/kg are required for tiny dc of a few milli-
meters. Such high SAR levels are unlikely to be achieved
even if the SAR is increased by AM modulation. Finally, for
submillimeter dimensions, e.g., 100mm, excessive SAR peaks
>106W/kg are required to generate a significant hot spot.
We can quickly deduce from Equation (10b) that, for targets
(e.g., proteins) in a cell membrane of 10-nm size, SAR levels
of >1014W/kg are required in order to generate a tempera-
ture-dependent effect. This is clearly an unrealistic
requirement.
Discussion
The AM-RF radiation technique is reported to employ RF for
heating (here, 13.56MHz) as well as VLF radiation (1Hz to
10 kHz). The latter employs a completely different mechanism
to dissipate energy via currents in a conductive medium and
may enhance the SAR in aqueous tumors. This additional
intratumoral power deposition SARTM (VLF) requires demodu-
lation and is said to be locally restricted to malignant cells
because of the specific microenvironment frequently found
in tumors and the peritumoral area [19]. For our theoretical
analyses, we assumed a considerably higher power in the
extracellular space according to a simplified tumor model
(Figure 2). Note that, to identify an appropriate VLF range for
optimization of this selective effect, matching procedures
may be useful [28]. Further, for demodulation, we require a
rectifying component; this is obviously accomplished by cell
membranes in contact with the extracellular space. Notably,
the effects of different frequency ranges have been applied
Figure 6. Diameters d of spherical hot spots (hmax¼ 6 C) versus required SAR
peaks in sphere. Three colored ranges of hot spot development according to
the degree of power enhancement K by VLF modulation are shown. For RF
alone (K¼ 0), up to SAR¼ 100W/kg, only necrotic/aqueous areas of centimeter
size can be heated. For high power dissipation via VLF modulation (K¼ 100)
above SAR¼ 10,000W/kg, necrotic/aqueous areas down to millimeter d are
effectively heated; however, necrotic/aqueous areas of microscopic dimensions
(e.g., d of 100mm) are still excluded. For areas of d 100 mm, excessive (unreal-
istic) values of SAR> 1,000,000W/kg are required. This general diagram is also
valid for microscopic d from micrometer down to nanometer scales (nanoheat-
ing range), requiring SAR values of up to a quadrillion (Equation 10b).
Figure 5. Temperature distributions for SAR peaks in spheres of 5-mm (bot-
tom) or 10-mm (top) diameter, illustrating the possibility of ‘point heating’. For
lesions of 1 cm, extremely large SAR of hundreds of Watts per kilogram are
required to obtain a relevant temperature >41 C (still far from cytotoxic tem-
peratures). On the other hand, temperature elevations of centimeter range
around the lesion are measurable. Therefore, ‘point heating’ in the absence of
bulk heating is physically impossible. The formula for the maximum tempera-
ture increase hmax in the lesion center (Figure 1) or the ECF (Figure 2) is given
together with the temperature increase h0 at the edge. The temperature at the
ordinate is given by 37.5 Cþh (using Equations 5a and 5b).
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for therapeutic ultrasound through modulation with a lower
frequency [31], even though that mechanism is completely
different to the mechanism discussed here.
In the preclinical studies cited above [14–18], a higher cell
kill (determined by various surrogate parameters) was
achieved with application of the mEHT technique in compari-
son with water bath heating or RF heating, through adjust-
ment to achieve the same (mean) temperature in the
specimens (i.e., cell suspensions, experimental tumors). These
phenomena were overwhelmingly explained via the hypoth-
esis that small (undetected) hot spots occur in the mEHT
experiment. Some researchers have hypothesized that cell
kill occurs on a millimeter scale, while the mean temperature
in the reference point remains almost constant.
However, our physical analysis suggests that such tem-
perature-dependent effects cannot fully explain the data.
According to Figures 5 and 6, relevant temperature increases
on a millimeter (or even sub-millimeter) scale are improb-
able, because unrealistic SAR delta peaks are required, e.g.,
SAR> 10,000W/kg for a sphere of 1-mm diameter. Even for a
sphere of 1 cm, already having macroscopic dimensions, the
SAR is either very high (>200W/kg) or the temperature
increase is only a few degrees Celsius (2 C for 100W/kg);
this increase is insufficient for cell damage. Furthermore, the
temperature increase has a range of several d of the heated
lesion in all directions (Figure 5) and, therefore, a measurable
macroscopic temperature increase should also occur.
According to Figure 2, this conclusion is even valid for an
aqueous tumor, if the SAR peak of diameter d is replaced by
a much more extended network of width d. Thus, we find
the same limitations. Note that Figure 2 presents the most
optimistic tumor model with respect to microscopic heating
effects. Heterogeneities and tumor stroma typically reduce
the power deposition in the extracellular space and further
limit the temperature-dependent effects.
In summary, we cannot exclude a slight circumscribed tem-
perature increase of a few degrees Celsius. However, these
slight inhomogeneities of the temperature distribution cannot
explain the extremely large differences in cell kill. The discus-
sion of ‘point heating’ is not new [32], and is still implicitly
proposed if temperature-dependent biological effects are
postulated in the absence of bulk heating. A similar discussion
has again arisen using the buzzword ‘nanoheating’, which has
essentially the same meaning as ‘point heating’.
Nanomedicine researchers have evaluated heating of a single
cell or a microscopic cell cluster to a cytotoxic temperature
through use of intracellular nanoparticles [33,34]. Realistic
estimations of the expectable nanoparticle power absorption
indicate that we are far from heating of a single cell, because
the required intracellular SAR would exceed one million Watts
per kilogram for a region of <100 mm, according to Figure 6
[6]. For a region of 10 nm, which is most likely intended in the
context of nanoheating, trillions of Watts per kilogram
(>200 1012W/kg) are required to achieve a corresponding
temperature increase of 6 C, according to Equation (10b).
Next, the possibility of non-temperature-dependent
effects can be considered. In the VLF range, ion movements
at and through the membranes may cause chemical
imbalances. If so, the local cell environment affects the extent
and impact of any chemical stress. For example, electrochem-
ical effects may occur more easily in the tumor microenviron-
ment with its wide ECF network (Figure 2). The discussion of
non-thermal effects on viable cells in general [35–37], and of
VLF electromagnetic fields in particular, has a long history
[38–40]. The resting potential along the cell membranes (–90
to –50mV along <10 nm) generates an extraordinarily high E
field of 107 V/m. The common consensus is that we require
E> 1000 V/m to exceed the thermal noise. Such E fields are
beyond the therapeutic level (Table 1). However, the min-
imum field strength (the so-called ‘thermal noise limit’) neces-
sary to achieve a cell response remains unclear. Different
sophisticated electrical models of the membrane have pro-
vided completely diverging estimations of the electric noise
[38–40], indicating the complexity of this issue. However, the
thermal noise limit is a key parameter if non-equilibrium
external signals must be comparable to the thermal noise
[41]. Obviously, the presence of pumps, transporters and
channels (pores) embedded in a lipid bilayer must be consid-
ered in a valid theory, but this field is still largely unexplored.
Therefore, ‘guided’ nonequilibrium VLF currents as induced in
the tumor microenvironment may have a much stronger
effect on the living cells than expected. One search strategy
for non-temperature-dependent effects involves investiga-
tions conducted on various ion channels (e.g., potassium or
calcium), which demodulate the AM-RF and may be influ-
enced/triggered/modified by the VLF E fields according to
their specific functionality.
Previously, Szasz et al. [42] analyzed the consequences of
depositing the power in the extracellular medium and postu-
lated a heat flow that would induce various non-equilibrium
thermal microprocesses. However, on a microscopic scale of
10 nm (cell membrane) to 10 mm (cell diameter), the relax-
ation times (Table 1) are very short, enforcing thermal equi-
librium after nanosecond to millisecond periods. We
conclude that, after power activation, a microscopic tempera-
ture distribution steady state is achieved within some milli-
seconds; hence, our steady state analysis is valid. Recently,
Papp et al. [43] suggested that the non-temperature-depend-
ent effects of mEHT can be explained by considering E field
interactions with lipid rafts, which arise more frequently in
some tumor cell membranes than in normal tissue [44].
However, no experimental validation exists for this asserted
mode of action.
In summary, the existence of non-temperature-dependent
effects during mEHT is under debate as the specific proof
still awaits experimental substantiation. Because mEHT is typ-
ically performed at low power levels (e.g., 130W in [12]), the
achieved temperatures are probably also low (e.g., 38–39 C).
Typically, they are not measured. Therefore, the label
‘hyperthermia’ is probably misleading and could be replaced
by ‘electromagnetic treatment’ or the like.
Conclusions
In this study, a possible additional effect of VLF-AM modula-
tion of a carrier RF in tumors was evaluated from physical
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principles. Hence, we found that temperature-dependent
mechanisms cannot be involved. Further investigations are
recommended to evaluate the possible occurrence of non-
temperature-dependent effects involving membranes and
the local cell environment.
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